Inhaled steroids in patients admitted to hospital with pneumonia

T. Rehman, V. Somani, C. McGeary, R. Randhawa, A. Kavidasan, M. Bhattacharya (Milton Keynes, United Kingdom)

Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Session: Different interesting issues in respiratory infections: 1
Session type: Thematic Poster Session
Number: 2554
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractE-poster

Abstract

Background It is well established that high dose inhaled steroids increase risk of pneumonia in COPD. As use of inhaled steroids rise, it poses a dilemma for practising physicians in patients with pneumonia. High mortality of patients with pneumonia at our hospital led to a retrospective audit, giving us an opportunity to look at steroid inhaler usage among them.Methods Patients with pneumonia admitted to Milton Keynes Hospital from 01.07.12 to 30.06.13 were audited. Data for age, sex, length of stay, co-morbidity, medication and outcome were collected.Results 49 patients were admitted with 55 episodes of pneumonia. 29 were male and 20 female. Median age was 73 years (18-86 years) and mean LOS of 19.7 days. 26 patients did not use any inhalers. 21 were on inhaled steroids of which 18 (86%) were on fluticasone/salmeterol, 2 (10%) on budesonide/formeterol and 1(4%) was on beclomethasone/formeterol combination. All patients on inhalers either had COPD, bronchiectasis, asthma or lung fibrosis. Mean LOS for those on fluticasone/salmeterol was 26.8 days compared to mean LOS of 14.5 days for all others. Overall mortality was 18 out of 49 patients (37%). In those on fluticasone/salmeterol it was 9 out of 18 (50%) while 11 out of 31(35%) not on inhalers died.Conclusion While limited by numbers, our audit did reveal a high prevalence of fluticasone/salmeterol usage among patients with pre-existing lung disease and pneumonia, with higher length of stay and mortality. Other large scale studies draw similar conclusion, warranting a review of inhaled steroid prescribing in patients who have had, or are susceptible to pneumonia.1. Janson et al; BMJ 2013; 346:33062. Suissa et al; Thorax 2013; 68: 1029-1036.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Rehman, V. Somani, C. McGeary, R. Randhawa, A. Kavidasan, M. Bhattacharya (Milton Keynes, United Kingdom). Inhaled steroids in patients admitted to hospital with pneumonia. Eur Respir J 2014; 44: Suppl. 58, 2554

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does previous warfarin treatment effect complications and outcome in hospitalised patients with community-acquired pneumonia?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Respiratory viral infections in community-acquired pneumonia and exacerbation of COPD: One year survey at a Japanese university hospital
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014


Nursing and healthcare-associated pneumonia requiring hospital admission: Microbiology and clinical outcomes
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


PICTURE: Clinical pattern and pneumococcal infections in patients with community-acquired pneumonia (CAP) admitted to emergency department
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014

Relationship between the use of inhaled steroids and early outcomes in community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Features of pneumonia diagnostics in burn trauma patients
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014



Immunoglobulin levels and severity of community-acquired pneumonia (CAP)
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014


Patterns of antibiotic prescribing for pneumonia at the outpatient to inpatient transition
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Association of breastfeeding and respiratory infections in infants
Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children
Year: 2014

Roomsharing in hospitalized children with bronchiolitis
Source: International Congress 2014 – Virus-triggered lower respiratory disease in children
Year: 2014


Severe community-acquired pneumonia in alcoholic patients hospitalized in intensive care unit
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016


Acute respiratory distress syndrome in patients admitted for community-acquired pneumonia
Source: International Congress 2014 – ARDS, skeletal muscles, physiology and weaning
Year: 2014


Effectiveness of immune stimulatory therapy in patient with severe community-acquired pneumonia (CAP)
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014


Length of hospital stay in community acquired pneumonia
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014


30 day mortality and eosinopenia in patients with pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014

Prior antibiotics and outcomes in patients hospitalized with pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015

The outcome of community-acquired pneumonia in patients with COPD, asthma and ILD - a case-control study
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


Antibiotic prescription patterns for treating respiratory infections across intensive care unit (ICUs) in India
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016


Health care-associated pneumonia and community-acquired pneumonia: A single-center experience
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015

Clinical features of nursing and healthcare-associated pneumonia in patients who underwent tube feeding
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014